Br J Pharmacol. 2012 Feb;165(3):741-53. doi: 10.1111/j.1476-5381.2011.01603.x.
Cardamonin sensitizes tumour cells to TRAIL through ROS- and CHOP-mediated up-regulation of death receptors and down-regulation of survival proteins.
Source
Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abnormal Science Blog
0 件のコメント:
コメントを投稿